Diagnosing Alzheimer’s disease using artificial intelligence

  • Language impairment is a known biomarker of Alzheimer’s disease (AD) and other neurodegenerative disorders. Speech analysis using artificial intelligence (AI) has the potential to detect and predict AD.
  • GPT-3 is a large language model produced by OpenAI. This novel research utilized GPT-3 to predict dementia from spontaneous speech.
  • The authors concluded that GPT-3 can be used to accurately identify individuals with AD from healthy controls and accurately predict their cognitive testing score based on speech data alone. Access to a timely AD diagnosis is relatively rare. This tool has the potential to rapidly improve diagnostic times.